Gravar-mail: 26.4 A U.S. EXPERT CONSENSUS SURVEY ON THE USE OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC DRUGS IN PATIENTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER AND BIPOLAR DISORDER